Risk-sharing agreements are emerging as new market access solutions. The purpose of such schemes is to share the whole or a part of the financial risk associated with the use of a new therapy in real-world or non-investigational conditions. The agreement is primarily set to advance patient's access to the new therapy when the payer deems its ex-post financial risk exposure too high and consequently challenges the demanded price and/or reimbursement conditions. Risk-sharing agreements entail financial implications for both parties at stake, the payer and the manufacturer... 
More...
More...